Literature DB >> 5456717

Psychosis and other psychiatric manifestations of levodopa therapy.

G G Celesia, A N Barr.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5456717     DOI: 10.1001/archneur.1970.00480270003001

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


× No keyword cloud information.
  25 in total

Review 1.  Neuropsychiatry of the basal ganglia.

Authors:  H A Ring; J Serra-Mestres
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-01       Impact factor: 10.154

Review 2.  Psychotic symptoms in Parkinson's disease. From description to etiology.

Authors:  Spiridon Papapetropoulos; D C Mash
Journal:  J Neurol       Date:  2005-07       Impact factor: 4.849

3.  Schizophrenia: a theory.

Authors:  E Hartmann
Journal:  Psychopharmacology (Berl)       Date:  1976-08-26       Impact factor: 4.530

4.  Neuropsychiatric Complications of Parkinson Disease Treatments: Importance of Multidisciplinary Care.

Authors:  Jacob Taylor; William S Anderson; Jason Brandt; Zoltan Mari; Gregory M Pontone
Journal:  Am J Geriatr Psychiatry       Date:  2016-09-03       Impact factor: 4.105

Review 5.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 6.  [Modern treatment of parkinsonism].

Authors:  W Birkmayer; E Neumayer
Journal:  Z Neurol       Date:  1972

7.  The balance of biogenic amines as condition for normal behaviour.

Authors:  W Birkmayer; W Danielczyk; E Neumayer; P Riederer
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

Review 8.  Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors:  B K Young; R Camicioli; L Ganzini
Journal:  Drugs Aging       Date:  1997-05       Impact factor: 3.923

Review 9.  A risk-benefit assessment of drugs used in the management of Parkinson's disease.

Authors:  I Y Bodagh; D R Robertson
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

10.  L-dopa and arousal.

Authors:  T B Horvath; R A Meares
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-04       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.